2-(Trifluoromethyl)imidazo[1,2-a]pyridin-8-amine, 95.0%, 1g

4-CHLORO-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID ETHYL ESTER, 95%, 100mg

N1,N1,N4,N4-Tetra(pyridin-4-yl)benzene-1,4-diamine, 98%, 25g

(S)-5-(8,9,10,11,12,13,14,15-Octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-5H-dibenzo[b,f]azepine, 98%, 5g

3,6,9,12,15-Pentaoxaheptadecane-1,17-diamine, 98%, 100mg

1,2-BIS((2R,5R)-2,5-DIPHENYLPHOSPHOLAN-1-YL)ETHANE, 95%, 5g

N-Propylaniline, 95.0%, 1g

ethyl (2Z)-2-chloro-2-[2-(2-chloro-4-nitrophenyl)hydrazin-1-ylidene]acetate, 95.0%, 2g

5H-Indazol-5-one, 2,4,6,7-tetrahydro-2-methyl-, 98%, 10g

Récipient de réaction à bride plate cylindrique, gradué (1) Fond rond, DN 100, 160 mm, Hauteur, 360 mm, 1 Pièce

1-(3,5-DIFLUOROPHENYL)-N-METHYLMETHANAMINE HCL, 97.0%, 5g

4,7-Dichloroisobenzofuran-1,3-dione, 95.0%, 1g

N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-(trifluoromethyl)benzamide, 97%, 250mg